Subscribe

News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

|Articles|November 30, 2012

Supplements and Featured Publications

New Approaches to Measuring Value in Oncology Therapy
Volume 18
Issue 11 Suppl

Appendix B -- Value of Survival Gains in Chronic Myeloid Leukemia

Articles in this issue

over 13 years ago

Article

eAppendix -- New Approaches to Measuring Value in Oncology Therapy

over 13 years ago

Article

Appendix A -- Value of Survival Gains in Chronic Myeloid Leukemia

over 13 years ago

Article

Participating Faculty: New Approaches to Measuring Value in Oncology Therapy

over 13 years ago

Article

Coverage and Use of Cancer Therapies in the Treatment of Chronic Myeloid Leukemia

over 13 years ago

Article

Dynamic Cost-Effectiveness of Oncology Drugs

over 13 years ago

Article

The Option Value of Innovative Treatments in the Context of Chronic Myeloid Leukemia

over 13 years ago

Article

Value of Survival Gains in Chronic Myeloid Leukemia

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

AJMC original research managerial

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

AJMC Letter to the Editor

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

AJMC original research policy

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

AJMC commentary

Upper Payment Limit Implementation Risks for Patients, Pharmacies, and Providers

ByJulie A. Patterson, PharmD, PhD,Roswell A. Cole, PharmD, MPH,Jonathan D. Campbell, PhD, MS,John Michael O’Brien, PharmD, MPH

July 9th 2026

AJMC commentary

The New Oncology Blueprint: Integrating Clinical Intelligence for Sustainable Value

ByVivian T. E. Tar, PharmD, MBA

July 8th 2026

Trending on AJMC

SYNCHRONIZE-1 Through a Hepatologist's Lens: Liver Fat Reduction, Visceral Fat, and What Comes Next

Beyond GLP-1: The Biological Case for Dual Incretin Therapy in MASH

FDA Approves Enlicitide, First Oral PCSK9 for High Cholesterol

Prior Cancer History Predicts Second Cancers in Polycythemia Vera, Essential Thrombocythemia

Managing the Tafasitamab Triplet: Safety Profile, Adverse Events, and Clinical Implications from inMIND